Gossamer Bio (GOSS) Market Cap

Price: $0.9583
Market Cap: $217.75M
Avg Volume: 1.61M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.883
52W Range: $0.499-1.55
Website: Gossamer Bio

Market Cap Overview

Market Cap

$217.75M

Share Price

$0.9583

Shares Outstanding

227.22M


What is Gossamer Bio's Market Cap?

Gossamer Bio's current Market Cap as of today is $217.75M.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Gossamer Bio, the market cap is calculated as $0.9583 x 227.22M shares = $217.75M.

As a Micro Cap company, Gossamer Bio is a very small company that may be in its early stages.

Gossamer Bio Historical Market Cap

$1.50B$1.50B$1.20B$1.20B$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00Market CapJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Gossamer Bio Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Gossamer Bio, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$1.20B$1.20B$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00ValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Gossamer Bio's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:

  • Market Cap: $217.75M
  • Total Debt: $202.88M
  • Cash and Equivalents: $46.07M
  • Enterprise Value: $361.45M

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.

Gossamer Bio Annual Market Cap History

Year Market Cap Change
2025 $217.75M 6.40%
2024 $204.65M 46.94%
2023 $139.27M -24.12%
2022 $183.53M -78.32%
2021 $846.48M 27.77%
2020 $662.49M -22.57%
2019 $855.59M -21.04%
2018 $1.08B 143.25%
2017 $445.47M 0.00%
2016 $445.47M N/A

Frequently Asked Questions

Gossamer Bio's current market capitalization is $217.75M. This makes it a Micro Cap company, calculated by multiplying its current stock price of $0.9583 by 227.22M outstanding shares.

Gossamer Bio's enterprise value is $361.45M. This is calculated by adding total debt ($202.88M) to market cap and subtracting cash and equivalents ($46.07M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Gossamer Bio has 227.22M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Gossamer Bio is classified as a Micro Cap company. Micro-cap companies are the smallest publicly traded companies with market caps below $300 million.

Gossamer Bio's market cap is calculated by multiplying its current stock price ($0.9583) by its total number of outstanding shares (227.22M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for GOSS.